An effective digital therapeutic tool for patients with schizophrenia might include reminders for medication, integration for social support, and cognitive restructuring.
Study finds no difference in sexual functioning among patients with major depressive disorder who were treated with zuranolone compared with those receiving placebo.
Study finds long-acting injectable (LAI) antipsychotics to be associated with fewer emergency department visits and inpatient days among patients with schizophrenia.